Anzeige
Erschienen in:
01.12.2015 | Pancreas Club
Proceedings of the 49th Annual Pancreas Club Meeting
Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 12/2015
Einloggen, um Zugang zu erhaltenExcerpt
The 49th annual Pancreas Club meeting was held May 15th and 16th, 2015, at the Washington Court hotel in Washington, DC. Three hundred and three attendees included pancreatologists from 20 countries. Sixty-one oral presentations and 165 posters were presented over the 2-day meeting. Table 1 documents oral abstract titles with institutional affiliation. Full abstracts for all oral presentations and posters are available at the pancreas club website, http://pancreasclub.com. Representative papers from each of the eight sessions are summarized below.
Table 1
Oral abstract titles with institutional affiliation
|
Paper#
|
Title
|
Primary Institution
|
|---|---|---|
|
Scientific session I
|
||
|
Topic: PNET/prognostics
|
||
|
1
|
Operative vs. non-operative management of nonfunctioning pancreatic neuroendocrine tumors
|
Massachusetts General Hospital
|
|
2
|
Long-term outcomes of surgical management of pancreatic neuroendocrine tumors with synchronous liver metastases
|
Ancona, Italy; Lubeck, Germany
|
|
3
|
Trends in hospital volume and failure to rescue for pancreatic surgery
|
Johns Hopkins Hospital
|
|
4
|
HLA class I expression as a favorable prognostic biomarker in pancreatic ductal adenocarcinoma (PDAC)
|
Massachusetts General Hospital
|
|
5
|
A proposal for improved staging of pancreatic ductal adenocarcinoma after pancreaticduodenectomy
|
Johns Hopkins Hospital
|
|
6
|
Proposal of a new staging system for ampulla of Vater cancer with higher distinction ability; multinational study from Eastern and Western
|
Seoul National University, Korea
|
|
7
|
Para-aortic lymph nodes metastases from ductal adenocarcinoma of the pancreas: do they really make a difference
|
University of Verona, Italy
|
|
8
|
Long term survival in surgically resected pancreatic cancer: characteristics of 10-year survivors using the National Cancer Database
|
University of Colorado
|
|
Scientific session II
|
||
|
Topic: IPMN/access to care
|
||
|
9
|
International multicenter study to characterize the individual risk of malignancy in branch duct IPMN and proposal of nomogram
|
Multicenter, Korea and Japan
|
|
10
|
The risk of malignancy in 1,712 patients resected for intraductal papillary mucinous neoplasms (IPMN) of the pancreas: a report from the Pancreatic Verona, Memorial Sloan Kettering Surgical Consortium
|
Johns Hopkins, Massachusetts General
|
|
11
|
Tumor-associated neutrophils and malignant progression in intraductal papillary mucinous neoplasms: an opportunity for identification of high-risk disease
|
Memorial Sloan Kettering Cancer Center
|
|
12
|
The natural history of non-resected IPMN of the pancreas: a single institution experience
|
Karolinska Institute, Sweden
|
|
13
|
The impact of rurality and access to gastroenterologists on disparities in pancreas cancer staging and mortality
|
Southern Illinois University
|
|
14
|
Adherence to expected treatment for pancreatic cancer improves outcomes
|
University of Pittsburgh
|
|
15
|
Trends in receipt and timing of multimodality therapy in early stage pancreatic cancer
|
University of Texas Medical Branch
|
|
Scientific session III
|
||
|
Topic: surgical techniques
|
||
|
16
|
Pancreatogastrostomy versus pancreatojejunostomy for reconstruction after pancreatoduodenectomy (recopanc)—results of a multicenter randomized controlled trial
|
University Lübeck, Germany
|
|
17
|
Randomized clinical trial of duct-to-mucosa pancreaticogastrostomy of pancreatic stump versus hand-sewn closure after distal pancreatectomy
|
Hiroshima University, Japan
|
|
18
|
Distal pancreatectomy with celiac axis resection: what are the added risks?
|
Multicenter/Indiana University
|
|
19
|
Early national experience with laparoscopic pancreaticoduodenectomy (LPD) for ductal adenocarcinoma (PDCA): a comparison of LPD and open pancreatico-duodenectomy (OPD) from the National Cancer Data Base
|
Northshore/University of Chicago
|
|
20
|
Prospective trial of 200 consecutive pancreatico-duodenectomies with the Finnish binding pancreaticojejunostomy (FBPJ): a low frequency of pancreatic fistula
|
Tampere University Hospital, Finland
|
|
21
|
Mesopancreatic tumor stromal-negative resection defines radical resection of pancreatic head cancer and can be predicted by preoperative radiologic parameters
|
University Lübeck, Germany
|
|
22
|
Leakage of an invagination pancreaticojejunostomy may have lethal consequences
|
Thomas Jefferson/multicenter
|
|
23
|
Long term oncologic outcomes after robotic resections are not inferior to open for pancreas cancer
|
University of Pittsburgh
|
|
24
|
After pancreatectomy epidural dysfunction increases postoperative complications
|
St. Luke’s Hospital, Boise
|
|
25
|
Lymphadenectomy for periampullary cancer: prognostic role of different metastatic nodal stations and of the number of metastatic lymph nodes
|
Rome, Italy, and Lyon, France
|
|
Scientific session IV
|
||
|
Topic: pancreatitis
|
||
|
26
|
Quality of life trends in patients undergoing surgery for chronic pancreatitis
|
PGIMER Chandigarh, India
|
|
27
|
Timing of cholecystectomy after mild biliary pancreatitis: a randomised controlled multicenter trial
|
Multicenter, Netherlands
|
|
28
|
Total pancreatectomy and islet cell autotransplantation as salvage therapy for patients failing previous surgical interventions for chronic pancreatitis
|
University of Cincinnati
|
|
29
|
Early nasoenteric versus on demand feeding in predicted severe acute pancreatitis: a multicenter randomized controlled trial
|
Multicenter, Netherlands
|
|
30
|
Mischaracterization of pancreatic necrosectomy in ACS-NSQIP
|
Stanford University
|
|
31
|
Comparison between Ki-67 labelling index on EUS-guided fine-needle aspiration and relative surgical specimen after curative surgery: a single center experience of 49 consecutive cases
|
IRCSS Milan, Italy
|
|
Scientific session V
|
||
|
Topic: basic science studies in pancreatic cancer
|
||
|
32
|
CDK4/6 inhibitors are potent suppressors of pancreatic carcinoma growth
|
University of Texas Southwestern
|
|
33
|
A novel PARP inhibitor resistance mechanism mediated by the RNA-binding protein HuR
|
Thomas Jefferson University
|
|
34
|
Pharmacological inhibition of BET bromodomains suppresses tumor growth and prolongs survival in a preclinical model of pancreatic cancer
|
Massachusetts General Hospital
|
|
35
|
Very long-term survival following resection for pancreatic cancer is not explained by common genetic alterations: results of whole-exome sequencing analysis
|
Johns Hopkins University
|
|
36
|
A novel immunocompetent murine model of pancreatic cancer with robust stroma: a valuable tool for pre-clinical evaluation of new therapies
|
University of Minnesota
|
|
37
|
Targeting tumor-associated hypoxia to overcome chemoresistance in pancreatic ductal adenocarcinoma
|
Thomas Jefferson University
|
|
38
|
Anti-TGF-beta antibody inhibits Treg pathway and induces anti tumor effector T cell responses in a vaccine-dependent manner
|
Johns Hopkins University
|
|
39
|
Copy number variation in cell free DNA in pancreatic cancer patients undergoing neoadjuvant therapy
|
Medical College of Wisconsin
|
|
Scientific session VI
|
||
|
Topic: perioperative outcomes
|
||
|
40
|
Characteristics and natural history of chyle leak following pancreatectomy
|
Johns Hopkins Hospital
|
|
41
|
Mortality following pancreatoduodenectomy: the influence of fistula risk
|
University of Pennsylvania
|
|
42
|
Drain management following pancreatoduodenectomy: reappraisal of a prospective randomized trial using risk stratification
|
University of Pennsylvania
|
|
43
|
Clinical risk score to predict pancreatic fistula after pancreatoduodenectomy: independent external validation for open and laparoscopic approaches
|
Mayo Clinic
|
|
44
|
Prospective scoring of all adverse events within 90 days: the standard for reporting surgical outcomes after pancreatectomy
|
MD Anderson Cancer Center
|
|
45
|
Discordance between perioperative antibiotic treatment and wound infection cultures in patients undergoing pancreaticoduodenectomy: a multicenter 5-year study
|
Multicenter, Mass General, U Penn, VERONA
|
|
46
|
A novel risk scoring system reliably predicts readmission following pancreatectomy
|
Johns Hopkins University, U Penn
|
|
47
|
The results of two randomized clinical trials to reduce delayed gastric emptying after pancreaticoduodenectomy
|
Wakayama University, Japan
|
|
48
|
Pancreaticojejunostomy stricture after pancreatoduodenectomy: outcomes after operative revision
|
Indiana University
|
|
49
|
Natural history of the pancreatic remnant after resection of IPMN: preliminary results from a multi-institutional international study
|
Karolinska Institute/multinational
|
|
50
|
A contemporary evaluation of the cause of death and long-term quality of life after total pancreatectomy
|
Johns Hopkins
|
|
51
|
Metabolic effect of pancreatoduodenectomy: in comparison with distal pancreatectomy
|
Seoul National University, Korea
|
|
Scientific session VII
|
||
|
Topic: neo-adjuvant treatment and borderline resectable pancreatic cancer
|
||
|
52
|
Neoadjuvant chemoradiation for T4 pancreatic adenocarcinoma: a gemcitabine, docetaxel, and capecitabine protocol offers superior outcomes
|
Columbia University
|
|
53
|
The role of neoadjuvant stereotactic body radiation therapy in borderline resectable and locally advanced pancreatic cancer
|
Johns Hopkins Hospital
|
|
54
|
Peri-operative outcomes following pancreatectomy with concomitant arterial procedures
|
Mayo Clinic
|
|
55
|
Pancreatectomy plus resection of peripancreatic vessels: impact of post-operative complications on long-term survival
|
University of Pisa, Italy
|
|
56
|
Importance of preoperative ca 19-9 levels in patients with localized pancreatic cancer treated with neoadjuvant therapy
|
Medical College of Wisconsin
|
|
57
|
Impact of chemoradiotherapy followed by surgery for locally advanced adenocarcinoma—comparison of clinicopathological features between single-agent gemcitabine and s-1/gemcitabine combination therapy
|
Mie University School of Medicine, Japan PANCREATIC
|
|
58
|
Neoadjuvant therapy with anatomical borderline pancreatic ductal adenocarcinoma. Does it make difference?
|
Johns Hopkins Hospital
|
|
59
|
Survival outcomes of patients with resectable pancreatic cancer receiving neoadjuvant therapy
|
Medical College of Wisconsin
|
|
60
|
A tale of two cities: reconsidering adjuvant radiation in pancreatic cancer care
|
Beth Israel Deaconess Medical Center
|
|
61
|
Timing of staging diagnostic laparoscopy prior to neoadjuvant therapy in patients stratified according to AHPBA/SSO/SSAT consensus definitions of resectability
|
Dartmouth Hitchcock Medical Center
|